Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Common Equity (2020 - 2026)

MDxHealth has reported Common Equity over the past 7 years, most recently at -$20.2 million for Q1 2026.

  • For Q1 2026, Common Equity changed N/A year-over-year to -$20.2 million; the TTM value through Mar 2026 reached -$20.2 million, changed N/A, while the annual FY2025 figure was -$12.1 million, 181.49% down from the prior year.
  • Common Equity was -$20.2 million for Q1 2026 at MDxHealth, down from -$12.1 million in the prior quarter.
  • Across five years, Common Equity topped out at $14.8 million in Q4 2024 and bottomed at -$20.2 million in Q1 2026.
  • The 5-year median for Common Equity is $7.2 million (2023), against an average of -$191800.0.
  • Year-over-year, Common Equity soared 105.9% in 2024 and then plummeted 181.49% in 2025.
  • Over 5 years, Common Equity stood at $9.3 million in 2022, then dropped by 22.62% to $7.2 million in 2023, then soared by 105.9% to $14.8 million in 2024, then crashed by 181.49% to -$12.1 million in 2025, then tumbled by 67.26% to -$20.2 million in 2026.
  • The last three reported values for Common Equity were -$20.2 million (Q1 2026), -$12.1 million (Q4 2025), and $14.8 million (Q4 2024) per Business Quant data.